scispace - formally typeset
C

Charles L. Brooks

Researcher at Ohio State University

Publications -  50
Citations -  1641

Charles L. Brooks is an academic researcher from Ohio State University. The author has contributed to research in topics: Receptor & Prolactin receptor. The author has an hindex of 23, co-authored 50 publications receiving 1545 citations.

Papers
More filters
Journal ArticleDOI

Albumin binding to FcRn: distinct from the FcRn-IgG interaction.

TL;DR: The results suggest that the FcRn-albumin interaction has unique features distinct from Fc Rn-IgG binding despite the overall similarity in the pH-dependent binding mechanism by which both ligands are protected from degradation.
Journal ArticleDOI

Alpha-lactalbumin unfolding is not sufficient to cause apoptosis, but is required for the conversion to HAMLET (human alpha-lactalbumin made lethal to tumor cells).

TL;DR: It is concluded that partial unfolding of α‐lactalbumin is necessary but not sufficient to trigger cell death, and that the activity of HAMLET is defined both by the protein and the lipid cofactor.
Journal ArticleDOI

Molecular Mechanisms of Prolactin and Its Receptor

TL;DR: This review critically evaluates selected literature that informs the mechanisms of the three lactogenic hormones, compares the mechanism with those of other class 1 ligand/receptor pairs, and identifies information that will be required to resolve mechanistic ambiguities.
Journal ArticleDOI

Identification and characterization of a regulatory domain on the carboxyl terminus of the measles virus nucleocapsid protein.

TL;DR: Results show that the C-terminal 24 amino acids of the N protein represent a regulatory domain containing a functional motif that mediates a direct interaction with Hsp72, based upon the truncation of N proteins used to support minireplicon reporter gene expression.
Journal ArticleDOI

Mutation of Serine 90 to Glutamic Acid Mimics Phosphorylation of Bovine Prolactin

TL;DR: The data indicate that the phosphorylation of serine 90 is responsible for the reduction in biological activity of phosphorylated bovine prolactin.